Article Details

Wedbush Trims BioMarin Pharmaceutical (NASDAQ:BMRN) Target Price to $110.00

Retrieved on: 2018-05-07 21:18:45

Tags for this article:

Click the tags to see associated articles and topics

Wedbush Trims BioMarin Pharmaceutical (NASDAQ:BMRN) Target Price to $110.00. View article details on hiswai:

Excerpt

<div><b>Quantum Capital Management</b> boosted its holdings in BioMarin Pharmaceutical by 15.7% in the first quarter. <b>Quantum Capital Management</b> now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up